- Home
- » Tags
- » Ranimustine
Top View
- Stembook 2018.Pdf
- Case Report Fatal Veno-Occlusive Disease (VOD)
- Development of Newly Synthesized Chromone Derivatives with High Tumor Specificity Against Human Oral Squamous Cell Carcinoma
- Promising Survival for Patients with Glioblastoma Multiforme Treated with Individualised Chemotherapy Based on in Vitro Drug Sensitivity Testing
- Printable Version [PDF]
- Orbital MALT Lymphoma After Autologous Stem Cell Transplantation for Follicular Lymphoma As Relapse of Diffuse Large B-Cell Lymphoma
- (12) United States Patent (1O) Patent No.: US 8,173,115 B2 Decuzzi Et Al
- (NCCN Guidelines®) T-Cell Lymphomas
- Optimizing Management of Patients with Adult T Cell Leukemia-Lymphoma
- Aggressive Non-Hodgkin Lymphoma
- Viral Oncology: Molecular Biology and Pathogenesis
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- (12) Patent Application Publication (10) Pub. No.: US 2016/0220537 A1 GARNER Et Al
- Proposal for the Inclusion of Mesna (Sodium 2-Mercaptoethane Sulfonate)
- United States Patent $835 a 88: As: Inhibitor 1-((R)-3-(4-Amino-3-(4
- Revisiting Intrathecal Therapy in Infants and Children Sharon Conroy, Martin Garnett, Michael Vloeberghs, Richard Grundy, Ian Craven, David Walker
- United States Patent (10) Patent No.: US 8,173,177 B2 Dao Et Al
- MCVAC) Regimen Followed by Autologous Peripheral Blood Stem Cell Transplantation for High-Risk Diffuse Large B-Cell Lymphoma
- A Quantitative Structure – Toxicity Relationship of Drugs on Rat Summary
- Adult T-Cell Leukemia/Lymphoma Fact Sheet
- Pharmacotherapy of Peripheral T-Cell Lymphoma: Review of the Latest Clinical Data
- United States Patent (19) 11 Patent Number: 5,811,547 Nakamichi Et Al
- 1078-0432.CCR-15-1412.Full.Pdf
- Cytostatics in the Aquatic Environment: Analysis, Occurrence, and Possibilities for Removal
- Treatment of Adult T-Cell Leukemia
- Biology of Blood and Marrow Transplantation
- Bone Marrow Uptake of Thallium-201 Before and After Therapy in Multiple Myeloma
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- 1 a Comprehensive Review of Economic Evaluations of Therapeutic Drug Monitoring Interventions for Cancer Treatments Dinusha T Vi
- Ranimustine (Rinn) ZD-1694
- (NCCN Guidelines®) Non-Hodgkin's Lymphomas
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- An Open Access Database of Licensed Cancer Drugs Pan Pantziarka 1,2, §, Rica Capistrano 1, Arno De Potter 3, Liese Vandeborne 1, Gauthier Bouche 1
- Adult T-Cell Leukemia/Lymphoma
- Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
- Ep 3348266 A1
- Nd Mmppregimens in the Treatment of Multiple Myeloma
- (12) United States Patent (10) Patent No.: US 8.241,668 B2 Uhrich (45) Date of Patent: * Aug